about
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorderThe ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic dataSequence and expression of human GABAA receptor alpha 1 and beta 1 subunitsMolecular cloning and expression of a chloride ion channel of cell nucleiA missense mutation in the gene encoding the alpha 1 subunit of the inhibitory glycine receptor in the spasmodic mouseGenome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorderKinetic determinants of agonist action at the recombinant human glycine receptorDjinn Lite: a tool for customised gene transcript modelling, annotation-data enrichment and explorationNovel genetic loci underlying human intracranial volume identified through genome-wide associationGeneral strategy for the generation of human antibody variable domains with increased aggregation resistanceGSK3B polymorphisms alter transcription and splicing in Parkinson's diseaseAdenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cellsGenome-wide association study reveals two new risk loci for bipolar disorderLocalization of the adenosine A2b receptor subtype gene (ADORA2B) to chromosome 17p11.2-p12 by FISH and PCR screening of somatic cell hybridsLocalization of the glycine receptor alpha 1 subunit gene (GLRA1) to chromosome 5q32 by FISHFunctional chloride channels by mammalian cell expression of rat glycine receptor subunitIdentification of intracellular and extracellular domains mediating signal transduction in the inhibitory glycine receptor chloride channelThe chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cellsGSK3B and MAPT polymorphisms are associated with grey matter and intracranial volume in healthy individualsQuantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study GroupDistinct physiological mechanisms underlie altered glycinergic synaptic transmission in the murine mutants spastic, spasmodic, and oscillatorMolecular cloning and amino acid sequence of rat enkephalinaseClinical and biomarker changes in dominantly inherited Alzheimer's disease.Predicted structure of the extracellular region of ligand-gated ion-channel receptors shows SH2-like and SH3-like domains forming the ligand-binding siteCommunity attitudes towards mental health interventions for healthy people on the basis of genetic susceptibility.Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).Genome-wide studies of verbal declarative memory in nondemented older people: the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium.Role of charged residues in coupling ligand binding and channel activation in the extracellular domain of the glycine receptor.Mechanisms of channel gating of the ligand-gated ion channel superfamily inferred from protein structure.Regional variability of imaging biomarkers in autosomal dominant Alzheimer's diseasePreclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility.Genetics of ageing-related changes in brain white matter integrity - a review.Concordance between direct and imputed APOE genotypes using 1000 Genomes data.A nonsense mutation in the alpha1 subunit of the inhibitory glycine receptor associated with bovine myoclonus.PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease.Pedigree with frontotemporal lobar degeneration--motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9.Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer's disease.Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.
P50
Q22242975-FDE38435-AECA-4EC5-A539-BB902077BA5FQ24289484-61E33950-DC20-4E05-9462-42AE1FF34A53Q24292885-5E591337-2540-4E52-AE5B-0E540B9F0AB9Q24318734-B24B63C9-7E71-4057-8F3D-1377F9D7EDB6Q24321378-F4019E78-20E6-4FA1-9029-D15A0ECE0A46Q24634497-D52D33F2-0F2E-4CE3-8990-67FC7F301111Q24656965-B596F66F-D660-4D49-8BF1-7D4CCAFD2658Q25257507-5A6E41CE-5094-4096-A1C5-37913F5B4886Q27653381-0CEC7F1B-24D8-407A-BD11-F58FB5CC83BEQ27670560-AB33C724-55A3-4981-B7CF-CBB9F0ADD7C6Q28116939-E05B6EB6-5611-4197-83FD-68E57BD8B120Q28140854-AC827A22-AF94-478E-92D1-C263F76A75C0Q28235753-E3F91E1F-1247-4BC3-960A-8F8E711E0FA5Q28303802-F311C1F4-38D9-4451-83CF-BE02C8BCB4C2Q28304616-7C379F93-C10C-4F0D-82B9-554EA9792D06Q28340468-EDC15C79-63C1-4AA8-A616-00F92B766292Q28379427-27199C34-ED07-4352-9F25-2C14152FD0C1Q28508363-CB9E1FDF-9878-4E85-9740-4BC6D69A7C87Q28535250-F59D2EA0-8C14-49B7-8082-C4EDEB01ECD9Q28550984-953C2A39-6D48-4281-B849-6F06A29DDD11Q28588906-6C0FA8E2-1F4E-40CC-B5E0-616CA26DABF9Q28646012-41DC741A-A2EA-4781-988F-4D8A8B72DE52Q29619940-E6243C4C-52D9-4F60-906E-D6B86021DD0FQ30176558-D90A57B1-5ED0-42EA-B4CC-5C487CBFE29BQ30227397-B3F0204E-6C2A-4A70-B488-DF42F71107A2Q30244121-75F7BFBE-B4B4-4E27-841A-0DECBED02629Q30300864-F87BEC1E-818C-4BEB-B8F1-203CC465E9ECQ30336137-127314FA-2989-4A1B-9F40-58E1C8EDF628Q30341434-55E84BF1-B554-4083-A20F-FEEC4FDB7E0DQ30557788-F34B7FD6-034E-441D-ABCF-4C45C508E28DQ30561855-CD01A2CB-93F9-4D85-B7B1-247CD6D1308AQ30574842-214FDD90-F93C-47C4-A856-0F8A9FCF2B11Q30576270-EC574339-4AC8-43CC-B587-F612400789E3Q30829344-ABB2F7DC-5AEF-4A2E-AC2A-6F6AE65664F2Q31937610-6583FB0F-F266-47E3-B57A-7EB5CBE5756DQ33314334-94C98AB3-474C-4C5C-90C7-519D92852857Q33364603-FA1ECB21-C613-4E50-ADC9-49004767F11DQ33622086-C08AB65D-43CF-46F8-B731-AADE5CE1E530Q33681922-E69B165B-CCBE-4828-9ECE-0922D6176ACEQ33687554-0F24321B-227E-4C49-B924-220AEBF5C73F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Peter R Schofield
@ast
Peter R Schofield
@en
Peter R Schofield
@es
Peter R Schofield
@nl
Peter R Schofield
@sl
type
label
Peter R Schofield
@ast
Peter R Schofield
@en
Peter R Schofield
@es
Peter R Schofield
@nl
Peter R Schofield
@sl
altLabel
Peter Schofield
@en
prefLabel
Peter R Schofield
@ast
Peter R Schofield
@en
Peter R Schofield
@es
Peter R Schofield
@nl
Peter R Schofield
@sl
P1053
C-9669-2011
P106
P1153
57203081336
P21
P2456
P31
P3829
P496
0000-0003-2967-9662